GLENMARK LIFE SCIENCES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 822.8 INR | -0.95% |
|
+0.01% | +25.22% |
| May. 15 | Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion | RE |
| Apr. 25 | Transcript : Glenmark Life Sciences Limited, Q4 2024 Earnings Call, Apr 25, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| GLENMARK LIFE SCIENCES LIMITED | Other Pharmaceuticals | -0.95% | +0.01% | +25.22% | +53.32% | - | 1.22B | - | - | - |
